larotaxel
Term · Oncology and biomedicine · MLC-T-ONC-014718
A semi-synthetic derivative of the taxane 10-deacetylbaccatin III with potential antineoplastic activities. Larotaxel binds to tubulin, promoting microtubule assembly and stabilization and preventing microtubule depolymerization, thereby inhibiting cell proliferation. As it represents poor substrate for P-glycoprotein-related drug resistance mechanisms, this agent may be useful for treating multi-drug resistant tumors. Larotaxel penetrates the blood brain barrier.
| Identifier | MLC-T-ONC-014718 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | RPR 109881A; RPR 109881 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014718",
"term": "larotaxel",
"field": "Oncology and biomedicine",
"definition": "A semi-synthetic derivative of the taxane 10-deacetylbaccatin III with potential antineoplastic activities. Larotaxel binds to tubulin, promoting microtubule assembly and stabilization and preventing microtubule depolymerization, thereby inhibiting cell proliferation. As it represents poor substrate for P-glycoprotein-related drug resistance mechanisms, this agent may be useful for treating multi-drug resistant tumors. Larotaxel penetrates the blood brain barrier.",
"synonyms": [
"RPR 109881A",
"RPR 109881"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/larotaxel/"
}
Record 9,933 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.